Capital Advisors Ltd’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Sell
11
-3
-21% -$254 ﹤0.01% 1309
2026
Q1
$1K Hold
14
﹤0.01% 1299
2025
Q4
$2K Hold
14
﹤0.01% 1105
2025
Q3
$2K Hold
14
﹤0.01% 1096
2025
Q2
$2K Buy
14
+2
+17% +$220 ﹤0.01% 1101
2025
Q1
$1K Buy
12
+1
+9% +$69 ﹤0.01% 1271
2024
Q4
$1K Hold
11
﹤0.01% 1305
2024
Q3
$2K Hold
11
﹤0.01% 1108
2024
Q2
$2K Hold
11
﹤0.01% 1086
2024
Q1
$1K Hold
11
﹤0.01% 1276
2023
Q4
$1K Sell
11
-1
-8% -$60 ﹤0.01% 1227
2023
Q3
$1K Sell
12
-20
-63% -$1.44K ﹤0.01% 1219
2023
Q2
$3K Hold
32
﹤0.01% 968
2023
Q1
$2K Hold
32
﹤0.01% 943
2022
Q4
$2K Buy
32
+21
+191% +$1.12K ﹤0.01% 905
2022
Q3
$0 Hold
11
﹤0.01% 1520
2022
Q2
$0 Hold
11
﹤0.01% 1322
2022
Q1
$0 Buy
+11
New +$197 ﹤0.01% 1197

Other funds holding TMDX

Capital Advisors Ltd's TMDX Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Transmedics (TMDX) stake by 21% in Q2 2026, selling an estimated $254 and leaving 11 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Capital Advisors Ltd first reported a position in TMDX in Q1 2022 and has held it in 18 quarters since. The position peaked at $3K in Q2 2023. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Capital Advisors Ltd held 11 shares of Transmedics worth $1K as of Q2 2026.
  • Capital Advisors Ltd sold 3 Transmedics shares in Q2 2026, an estimated $254.
  • Transmedics made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1309 holding.
  • Capital Advisors Ltd first reported a position in Transmedics in Q1 2022 and has held it in 18 quarters since.
  • Capital Advisors Ltd's Transmedics position peaked at $3K in Q2 2023.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.